Skip to main content
Fig. 5 | Alzheimer's Research & Therapy

Fig. 5

From: Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology

Fig. 5

Angiotensin-converting enzyme 2 (ACE-2) expression in mid-frontal cortex in Alzheimer’s disease. a and b ACE-2 displayed strong capillary labelling (black arrows) and abundant perivascular labelling of larger arterioles (scale bar = 100 μm). Shown in b at higher magnification (scale bar = 50 μm). b and c ACE-2 was present in astrocytes (scale bar = 50 μm). d Pre-adsorption of ACE-2 antibody with recombinant human ACE-2 abolished labelling, confirming antibody specificity (scale bar = 100 μm)

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193